Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications
MacTel demonstrates a progressive decline in visual and structural integrity over extended follow-up. While anti-VEGF therapy offers short-term benefits for MNV, its long-term efficacy remains limited. MH development, though rare, poses a significant challenge, with variable surgical outcomes.
Authors
- Özgür Artunay (ORCID: https://orcid.org/0000-0003-2002-7393)
- Metehan Şimşek (ORCID: https://orcid.org/0000-0002-5348-9829)
- Merve Özbek (ORCID: https://orcid.org/0000-0002-4280-5718)
- R Koçak (ORCID: https://orcid.org/0000-0003-3373-8434)
- İlker Hoşver
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Turkish Journal of Ophthalmology
- Published
- 2025-08-21
- DOI
- https://doi.org/10.4274/tjo.galenos.2025.19940
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00